| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Zawel Leigh is a See Remarks at Cullinan Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2021 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sell | 19,574 | $25.00 | $489,350.00 | -34.4% | -46.6% | -49.5% | |
| Oct 7, 2021 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sell | 1,079 | $25.00 | $26,975.00 | -1.9% | -36.0% | -48.3% | |
| Sep 20, 2021 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sell | 7,468 | $25.16 | $187,894.88 | -11.4% | -34.8% | -49.8% | |
| Sep 7, 2021 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sell | 28,118 | $28.95 | $814,016.10 | -30.1% | -41.8% | -53.9% | |
| Aug 23, 2021 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sell | 28,118 | $29.00 | $815,422.00 | -23.1% | -36.6% | -54.9% | |
| Aug 10, 2021 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sell | 28,118 | $26.77 | $752,850.35 | -4.3% | -17.3% | -51.1% |